Showing results (841-850 of 4,514) with videos related to

Sort By:
Pageof 452
Future Oncology (London, England)|July 27, 2012
'What matters to me': an international online survey of people treating, affected by and living with lung cancerGeraldine M Leydon, Maria Guerin, Caroline Eyles, et al.
Future Oncology (London, England)|June 30, 2020
Association between single nucleotide polymorphisms of DNA damage response pathway genes and increased risk in breast cancerAzhar Mehmood, Mahmood Akhtar Kayani, Malik Waqar Ahmed, et al.
Future Oncology (London, England)|April 27, 2021
Current state and comparison of the clinical development of bevacizumab, rituximab and trastuzumab biosimilarsLuis Pérez Díaz, Susana Millán, Nuran Chaban, et al.
Future Oncology (London, England)|April 28, 2021
Preclinical activity of cobimetinib alone or in combination with chemotherapy and targeted therapies in renal cell carcinomaLichen Zhang, Deqiong Xie, Yonghua Lei, et al.
Future Oncology (London, England)|April 28, 2021
Real-world genetic testing patterns in metastatic castration-resistant prostate cancerNeal Shore, Raluca Ionescu-Ittu, Lingfeng Yang, et al.
Future Oncology (London, England)|April 21, 2021
Analysis of risk factors for immune-related adverse events in various solid tumors using real-world dataKeitaro Shimozaki, Yasutaka Sukawa, Yasunori Sato, et al.
Future Oncology (London, England)|April 21, 2021
Real-world treatment patterns and healthcare resource use in patients with acute myeloid leukemia in Western EuropeMadhusudan Kabra, Luana Margotto, Fil Manuguid
Future Oncology (London, England)|April 16, 2021
ALTERTASTE: improving food pleasure and intake of oncology patients receiving chemotherapySara Spinelli, Enrico Mini, Erminio Monteleone, et al.
Future Oncology (London, England)|April 21, 2021
Quality of life assessment in renal cell carcinoma Phase II and III clinical trials published between 2010 and 2020: a systematic reviewAlessandro Rizzo, Veronica Mollica, Filippo Gustavo Dall'Olio, et al.
Future Oncology (London, England)|April 21, 2021
Single-dose netupitant/palonosetron versus 3-day aprepitant for preventing chemotherapy-induced nausea and vomiting: a pooled analysisRudolph M Navari, Gary Binder, Erminio Bonizzoni, et al.
Pageof 452